Position in DNTH
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$12,213,968
-$13,435,259 QoQ
Shares Held
145,543
-76.6% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNTH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tri Locum Partners LP holds $302,334,342 across 10 Biotechnology names. DNTH ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
255,332 | $58,402,088 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,314 | $57,743,873 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
103,288 | $54,068,169 | |
| 4 | NUVL |
Nuvalent, Inc.
|
308,506 | $31,606,439 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
158,663 | $29,995,240 | |
| 6 | ARGX |
Argenx SE
|
31,635 | $23,101,458 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
252,588 | $17,719,048 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
This page
|
145,543 | $12,213,968 |
All Filings in DNTH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,213,968 | 145,543 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $25,649,227 | 622,403 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,195,816 | 182,867 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||